| Traci Lynn Tague, MA, CCC-SLP | |
|
4440 W 95th St, Oak Lawn, IL 60453-2600 | |
| (708) 684-1989 | |
| Not Available |
| Full Name | Traci Lynn Tague |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4440 W 95th St, Oak Lawn, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003147968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.008233 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Traci Lynn Tague, MA, CCC-SLP 1218 W Wrightwood Ave, Unit G, Chicago, IL 60614-1224 Ph: (217) 417-6000 | Traci Lynn Tague, MA, CCC-SLP 4440 W 95th St, Oak Lawn, IL 60453-2600 Ph: (708) 684-1989 |
News Archive
More symptoms of depression and lower cognitive status are independently associated with a more rapid decline in the ability to handle tasks of everyday living, according to a study by Columbia University Medical Center researchers in this month's Journal of Alzheimer's Disease.
Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region "which accounts for around two-thirds of the 816 confirmed deaths so far from the disease," the AFP/channelnewsasia.com reports. "The outlook is especially unsettling for the estimated 380 million people grappling with winter in South America, where the A(H1N1) virus is speedily propagating," the news service writes.
People with type 1 diabetes who use insulin pump therapy face almost 50% less risk of dying from cardiovascular disease than those who take insulin by multiple daily injections. The British Medical Journal has published a study conducted at Sahlgrenska Academy.
Researchers at the University of Illinois at Chicago and Israel's Weizman Institute of Science have found that two antibiotics working together might be more effective in fighting pathogenic bacteria than either drug on its own.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration to market Xpert Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII).
› Verified 1 days ago
Anna Manilla, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 248-701-7523 | |
Erin M Shannon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4300 W 108th Pl, Oak Lawn, IL 60453 Phone: 708-423-3078 | |
Elizabeth Maeve Nolan, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4560 W 103rd St Ste 2, Oak Lawn, IL 60453 Phone: 708-860-5015 | |
Jennifer Andrekus, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9830 Brandt Ave, Oak Lawn, IL 60453 Phone: 708-423-7820 | |
Noreen Philbin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10620 S Kolin Ave, Oak Lawn, IL 60453 Phone: 708-228-1498 | |
Emily Quinn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10201 S Cicero Ave Ste F, Oak Lawn, IL 60453 Phone: 815-469-1500 Fax: 779-216-3069 |